Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.
Decensi A, Veronesi U, Miceli R, Johansson H, Mariani L, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Costa A, Perloff M, Malone WF, Formelli F. Decensi A, et al. Among authors: formelli f. Clin Cancer Res. 2003 Oct 15;9(13):4722-9. Clin Cancer Res. 2003. PMID: 14581342 Clinical Trial.
A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
Colombo N, Formelli F, Cantù MG, Parma G, Gasco M, Argusti A, Santinelli A, Montironi R, Cavadini E, Baglietto L, Guerrieri-Gonzaga A, Viale G, Decensi A. Colombo N, et al. Among authors: formelli f. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1914-9. doi: 10.1158/1055-9965.EPI-06-0183. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17035399 Clinical Trial.
Plasma testosterone and prognosis of postmenopausal breast cancer patients.
Micheli A, Meneghini E, Secreto G, Berrino F, Venturelli E, Cavalleri A, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Veronesi U, Formelli F. Micheli A, et al. Among authors: formelli f. J Clin Oncol. 2007 Jul 1;25(19):2685-90. doi: 10.1200/JCO.2006.09.0118. Epub 2007 Jun 4. J Clin Oncol. 2007. PMID: 17548841
Plasma retinol and prognosis of postmenopausal breast cancer patients.
Formelli F, Meneghini E, Cavadini E, Camerini T, Di Mauro MG, De Palo G, Veronesi U, Berrino F, Micheli A. Formelli F, et al. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):42-8. doi: 10.1158/1055-9965.EPI-08-0496. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19124479
Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.
Decensi A, Robertson C, Guerrieri-Gonzaga A, Serrano D, Cazzaniga M, Mora S, Gulisano M, Johansson H, Galimberti V, Cassano E, Moroni SM, Formelli F, Lien EA, Pelosi G, Johnson KA, Bonanni B. Decensi A, et al. Among authors: formelli f. J Clin Oncol. 2009 Aug 10;27(23):3749-56. doi: 10.1200/JCO.2008.19.3797. Epub 2009 Jul 13. J Clin Oncol. 2009. PMID: 19597031 Free PMC article. Clinical Trial.
Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide.
Johansson H, Bonanni B, Gandini S, Guerrieri-Gonzaga A, Cazzaniga M, Serrano D, Macis D, Puccio A, Sandri MT, Gulisano M, Formelli F, Decensi A. Johansson H, et al. Among authors: formelli f. Breast Cancer Res Treat. 2013 Dec;142(3):569-78. doi: 10.1007/s10549-013-2768-7. Epub 2013 Nov 17. Breast Cancer Res Treat. 2013. PMID: 24241787 Clinical Trial.
Effect of fenretinide on ovarian carcinoma occurrence.
De Palo G, Mariani L, Camerini T, Marubini E, Formelli F, Pasini B, Decensi A, Veronesi U. De Palo G, et al. Among authors: formelli f. Gynecol Oncol. 2002 Jul;86(1):24-7. doi: 10.1006/gyno.2002.6663. Gynecol Oncol. 2002. PMID: 12079295 Clinical Trial.
131 results